Flyer

Archivos de Medicina

  • ISSN: 1698-9465
  • Journal h-index: 29
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 10.14
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Short Communication - (2020) Volume 16, Issue 3

Line of Drugs to Treat Covid 19

Joe Thomas*

Jawaharlal Nehru University, Hyderabd, India

Corresponding Author:
Joe Thomas Jawaharlal Nehru University, Hyderabd, India E-mail: joe.thomas@gmail.com

Fecha de recepción: July 20, 2020, Fecha de aceptación: July 25, 2020, Fecha de publicación: July 28, 2020

Visit for more related articles at Archivos de Medicina

Short Communication

Most people who become ill with COVID-19 are going to be ready to recover reception. No specific treatments for COVID-19 exist immediately. But a number of an equivalent belongings you do to feel better if you've got the flu — getting enough rest, staying well hydrated, and taking medications to alleviate fever and aches and pains — also help with COVID-19.

When people get over COVID-19, their blood contains antibodies that their bodies produced to fight the coronavirus and help them recover. Antibodies are found in plasma, a component of blood. The donor antibodies help the patient fight the illness, possibly shortening the length or reducing the severity of the disease.

A recent report on a clinical test showed that the corticosteroid drug dexamethasone decreased the danger of dying in very ill hospitalized COVID-19 patients. It makes biologic sense for those patients who have developed a hyper-immune response (a cytokine storm) to the virus infection. In these cases, it's the immune system's overreaction that's damaging the lungs and other organs, and too often resulting in death.

Some French doctors advise against using ibuprofen (Motrin, Advil, many generic versions) for COVID-19 symptoms supported reports of otherwise healthy people with confirmed COVID-19 who were taking an NSAID for symptom relief and developed a severe illness, especially pneumonia. These are only observations and not supported scientific studies.

Early reports from China and France suggested that patients with severe symptoms of COVID-19 improved more quickly when given chloroquine or hydroxychloroquine. Some doctors were employing a combination of hydroxychloroquine and azithromycin with some positive effects.

Hydroxychloroquine and chloroquine are primarily wont to treat malaria and a number of other inflammatory diseases, including lupus and atrophic arthritis. Azithromycin may be a commonly prescribed antibiotic for streptococcal sore throat and bacterial pneumonia. Both drugs are inexpensive and readily available.

Remdesivir was developed to treat several other severe viral diseases, including the disease caused by Ebola virus (not a coronavirus). It works by inhibiting the power of the coronavirus to breed and make copies of itself: if it can't reproduce, it can't make copies that spread and infect other cells and other parts of the body.

There are several recommendations to enhance health Covid patient. supported the country and severity of viral load the treatment has been chosen by the doctor.

29086